Clinical trial NCT02770729 - References

Endophthalmitis — Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.

Citation(s)

•   Arieta CE, de Oliveira DF, Lupinacci AP, Novaes P, Paccola M, Jose NK, Limburg H
  Cataract remains an important cause of blindness in Campinas, Brazil. Ophthalmic Epidemiol. 2009 Jan-Feb;16(1):58-63. doi: 10.1080/09286580802575032.
•   Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons
  Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007 Jun;33(6):978-88.
•   Espiritu CR, Caparas VL, Bolinao JG
  Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg. 2007 Jan;33(1):63-8.
•   Friling E, Lundström M, Stenevi U, Montan P
  Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013 Jan;39(1):15-21. doi: 10.1016/j.jcrs.2012.10.037.
•   Haripriya A, Chang DF, Namburar S, Smita A, Ravindran RD
  Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital. Ophthalmology. 2016 Feb;123(2):302-8. doi: 10.1016/j.ophtha.2015.09.037. Epub 2015 Oct 30.
•   Javitt JC
  Intracameral Antibiotics Reduce the Risk of Endophthalmitis after Cataract Surgery: Does the Preponderance of the Evidence Mandate a Global Change in Practice? Ophthalmology. 2016 Feb;123(2):226-31. doi: 10.1016/j.ophtha.2015.12.011.
•   Kim SY, Park YH, Lee YC
  Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells. Clin Exp Ophthalmol. 2008 May;36(4):367-70. doi: 10.1111/j.1442-9071.2008.01771.x.
•   Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ
  Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol. 2005 Sep;140(3):497-504.
•   Lane SS, Osher RH, Masket S, Belani S
  Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg. 2008 Sep;34(9):1451-9. doi: 10.1016/j.jcrs.2008.05.034.
•   Matsuura K, Miyoshi T, Suto C, Akura J, Inoue Y
  Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan. J Cataract Refract Surg. 2013 Nov;39(11):1702-6. doi: 10.1016/j.jcrs.2013.05.036. Epub 2013 Sep 18.
•   Matsuura K, Suto C, Akura J, Inoue Y
  Comparison between intracameral moxifloxacin administration methods by assessing intraocular concentrations and drug kinetics. Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1955-9. doi: 10.1007/s00417-013-2294-7. Epub 2013 Apr 2.
•   Melo GB, Bispo PJ, Regatieri CV, Yu MC, Pignatari AC, Höfling-Lima AL
  Incidence of endophthalmitis after cataract surgery (2002-2008) at a Brazilian university-hospital. Arq Bras Oftalmol. 2010 Nov-Dec;73(6):505-7.
•   Shorstein NH, Winthrop KL, Herrinton LJ
  Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg. 2013 Jan;39(1):8-14. doi: 10.1016/j.jcrs.2012.07.031. Epub 2012 Oct 2.

Use of Intracameral Moxifloxacin for the Prevention of Acute Endophthalmitis Following Cataract Surgery: a Controlled and Randomized Clinical Trial

Details for clinical trial NCT02770729